Thomas Delerue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas Delerue has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Teumer
Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany
3 shared publications - Marcus Dörr
Department of Internal Medicine B, University Medicine Greifswald , Greifswald
3 shared publications - Melanie Waldenberger
Research Unit Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
3 shared publications - Alessandra Rossini
Eurac Research, Institute for Biomedicine (Affiliated to the University of Lübeck), 39100 Bolzano, Italy
2 shared publications - Benedetta Maria Motta
Department of Medicine, Surgery and Dentistry, “Scuola Medica Salernitana”, University of Salerno, 84081 Baronissi, Italy
2 shared publications - Chiara Volani
Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, 6020, Austria
2 shared publications
Latest Publications
- Open Access
- 8 October 2025
- Published by Springer Nature in Diabetologia
- Vol. 69 (1) , 127-145
DNA methylation of genes involved in lipid metabolism drives adiponectin levels and metabolic disease
Aims/hypothesis: Despite playing critical roles in the pathophysiology of type 2 diabetes and other metabolic disorders, the molecular mechanisms underlying circulating adipokine levels remain poorly understood. By identifying genomic regions involved in the regulation of adipokine levels and adipokine-mediated disease risk, we can improve our understanding of type 2 diabetes pathogenesis and inter-individual differences in metabolic risk. Methods: We conducted an epigenome-wide meta-analysis of associations between serum adiponectin ( n =2791) and leptin ( n =3661) and leukocyte DNA methylation at over 400,000 CpG sites across five European cohorts. The resulting methylation signatures were followed up using functional genomics, integrative analyses and causal inference methods. Results: Our findings revealed robust associations with adiponectin at 73 CpGs and leptin at 211 CpGs. Many of the identified sites were also associated with risk factors for the metabolic syndrome and located in enhancers close to relevant transcription factor binding sites. Integrative analyses additionally linked 35 of the adiponectin-associated CpGs to the expression of 46 genes, and 100 of the leptin-associated CpGs to the expression of 151 genes, with implicated genes enriched for lipid transport (e.g. ABCG1 ), metabolism (e.g. CPT1A ) and biosynthesis (e.g. DHCR24 ). Bidirectional two-sample Mendelian randomisation further identified two specific CpG sites as plausible drivers of both adiponectin levels and metabolic health: one annotated to ADIPOQ , the gene encoding adiponectin; and another linked to the expression of SREBF1 , an established modifier of type 2 diabetes risk known to exert its effects via adiponectin. Conclusions/interpretation: Taken together, these large-scale and integrative analyses uncovered links between adipokines and widespread, yet functionally specific, differences in regulation of genes with a central role in type 2 diabetes and its risk factors. Graphical
- 8 October 2025
- Published by Springer Nature in Diabetologia
- Vol. 69 (1) , 127-145
Open AccessDNA methylation of genes involved in lipid metabolism drives adiponectin levels and metabolic disease
Aims/hypothesis: Despite playing critical roles in the pathophysiology of type 2 diabetes and other metabolic disorders, the molecular mechanisms underlying circulating adipokine levels remain poorly understood. By identifying genomic regions involved in the regulation of adipokine levels and adipokine-mediated disease risk, we can improve our understanding of type 2 diabetes pathogenesis and inter-individual differences in metabolic risk. Methods: We conducted an epigenome-wide meta-analysis of associations between serum adiponectin ( n =2791) and leptin ( n =3661) and leukocyte DNA methylation at over 400,000 CpG sites across five European cohorts. The resulting methylation signatures were followed up using functional genomics, integrative analyses and causal inference methods. Results: Our findings revealed robust associations with adiponectin at 73 CpGs and leptin at 211 CpGs. Many of the identified sites were also associated with risk factors for the metabolic syndrome and located in enhancers close to relevant transcription factor binding sites. Integrative analyses additionally linked 35 of the adiponectin-associated CpGs to the expression of 46 genes, and 100 of the leptin-associated CpGs to the expression of 151 genes, with implicated genes enriched for lipid transport (e.g. ABCG1 ), metabolism (e.g. CPT1A ) and biosynthesis (e.g. DHCR24 ). Bidirectional two-sample Mendelian randomisation further identified two specific CpG sites as plausible drivers of both adiponectin levels and metabolic health: one annotated to ADIPOQ , the gene encoding adiponectin; and another linked to the expression of SREBF1 , an established modifier of type 2 diabetes risk known to exert its effects via adiponectin. Conclusions/interpretation: Taken together, these large-scale and integrative analyses uncovered links between adipokines and widespread, yet functionally specific, differences in regulation of genes with a central role in type 2 diabetes and its risk factors. Graphical
- Open Access
- 30 July 2025
- Published by Springer Nature in Human Genetics
- Vol. 144 (8) , 1-18
Genomic and molecular evidence that the LncRNA DSP-AS1 modulates desmoplakin expression
Cardiac desmosomes are specialized cell junctions responsible for cardiomyocytes mechanical coupling. Mutation in desmosomal genes cause autosomal dominant and recessive familial arrhythmogenic cardiomyopathy. Motivated by evidence that Mendelian diseases share genetic architecture with common complex traits, we assessed whether common variants in any desmosomal gene were associated with cardiac conduction traits in the general population. We analysed data of N = 4342 Cooperative Health Research in South Tyrol (CHRIS) study participants. We tested associations between genotype imputed variants covering the five desmosomal genes Desmoplakin (DSP), junction plakoglobin (JUP), plakophilin 2 (PKP2), desmoglein 2 (DSG2), and desmocollin 2 (DSC2), and P-wave, PR, QRS, and QT electrocardiographic intervals, using linear mixed models. Functional annotation and interrogation of publicly available genome-wide association study resources implicated potential connection with antisense long non-coding RNAs (lncRNAs), DNA methylation sites, and complex traits. Causality was tested via two-sample Mendelian randomization (MR) analysis and validated with functional in vitro follow-up in human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs). DSP variant rs2744389 was associated with QRS (P = 3.5 × 10−6), with replication in the Microisolates in South Tyrol (MICROS) study (n = 636; P = 0.010). Observing that rs2744389 was associated with DSP-AS1 antisense lncRNA but not with DSP expression in multiple Genotype-Tissue Expression (GTEx) v8 tissues, we conducted two-sample Mendelian randomization analyses that identified causal effects of DSP-AS1 on DSP expression (P = 6.33 × 10−5; colocalization posterior probability = 0.91) and QRS (P = 0.015). In hiPSC-CMs, DSP-AS1 expression downregulation through a specific GapmerR matching sequence led to significant DSP upregulation at both mRNA and protein levels. The evidence that DSP-AS1 has a regulatory role on DSP opens the venue for further investigations on DSP-AS1’s therapeutic potential for conditions caused by reduced desmoplakin production.
- 30 July 2025
- Published by Springer Nature in Human Genetics
- Vol. 144 (8) , 1-18
Open AccessGenomic and molecular evidence that the LncRNA DSP-AS1 modulates desmoplakin expression
Cardiac desmosomes are specialized cell junctions responsible for cardiomyocytes mechanical coupling. Mutation in desmosomal genes cause autosomal dominant and recessive familial arrhythmogenic cardiomyopathy. Motivated by evidence that Mendelian diseases share genetic architecture with common complex traits, we assessed whether common variants in any desmosomal gene were associated with cardiac conduction traits in the general population. We analysed data of N = 4342 Cooperative Health Research in South Tyrol (CHRIS) study participants. We tested associations between genotype imputed variants covering the five desmosomal genes Desmoplakin (DSP), junction plakoglobin (JUP), plakophilin 2 (PKP2), desmoglein 2 (DSG2), and desmocollin 2 (DSC2), and P-wave, PR, QRS, and QT electrocardiographic intervals, using linear mixed models. Functional annotation and interrogation of publicly available genome-wide association study resources implicated potential connection with antisense long non-coding RNAs (lncRNAs), DNA methylation sites, and complex traits. Causality was tested via two-sample Mendelian randomization (MR) analysis and validated with functional in vitro follow-up in human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs). DSP variant rs2744389 was associated with QRS (P = 3.5 × 10−6), with replication in the Microisolates in South Tyrol (MICROS) study (n = 636; P = 0.010). Observing that rs2744389 was associated with DSP-AS1 antisense lncRNA but not with DSP expression in multiple Genotype-Tissue Expression (GTEx) v8 tissues, we conducted two-sample Mendelian randomization analyses that identified causal effects of DSP-AS1 on DSP expression (P = 6.33 × 10−5; colocalization posterior probability = 0.91) and QRS (P = 0.015). In hiPSC-CMs, DSP-AS1 expression downregulation through a specific GapmerR matching sequence led to significant DSP upregulation at both mRNA and protein levels. The evidence that DSP-AS1 has a regulatory role on DSP opens the venue for further investigations on DSP-AS1’s therapeutic potential for conditions caused by reduced desmoplakin production.
- Open Access
Genomic and molecular evidence that the lncRNA DSP-AS1 modulates Desmoplakin expression
Cardiac desmosomes are specialized cell junctions responsible for cardiomyocytes mechanical coupling. Mutation in desmosomal genes cause autosomal dominant and recessive familial arrhythmogenic cardiomyopathy. Motivated by evidence that Mendelian diseases share genetic architecture with common complex traits, we assessed whether common variants in any desmosomal gene were associated with cardiac conduction traits in the general population. We analysed data of N=4342 Cooperative Health Research in South Tyrol (CHRIS) study participants. We tested associations between genotype imputed variants covering the five desmosomal genes DSP, JUP, PKP2, DSG2, and DSC2 , and P-wave, PR, QRS, and QT electrocardiographic intervals, using linear mixed models. Functional annotation and interrogation of publicly available genome-wide association study resources implicated potential connection with antisense lncRNAs, DNA methylation sites, and complex traits. Causality was tested via two-sample Mendelian randomization (MR) analysis and validated with functional in vitro follow-up in human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs). DSP variant rs2744389 was associated with QRS ( P =3.5×10 -6 ), with replication in the Microisolates in South Tyrol (MICROS) study (n=636; P =0.010). Observing that rs2744389 was associated with DSP-AS1 antisense lncRNA but not with DSP expression in multiple GTEx-v8 tissues, we conducted two-sample Mendelian randomization analyses that identified causal effects of DSP-AS1 on DSP expression ( P =6.33×10 -5 ; colocalization posterior probability=0.91) and QRS ( P =0.015). In hiPSC-CMs, DSP-AS1 expression downregulation through a specific GapmerR matching sequence led to significant DSP upregulation at both mRNA and protein levels. The evidence that DSP-AS1 has a regulatory role on DSP opens the venue for further investigations on DSP- AS1 ’s therapeutic potential for conditions caused by reduced desmoplakin production. Author Summary: Arrhythmogenic Cardiomyopathy is a severe condition mainly caused by pathogenic variants in genes encoding components of the cardiac desmosome, a specialised cell junction. Given complex traits and Mendelian diseases share common genetic background, we hypothesised that common variants in any of the five desmosomal genes ( DSP, JUP, PKP2, DSG2, and DSC2 ) could be associated with electrocardiographic measurements in general population individuals. Analyzing data from >4000 participants from the Cooperative Research In South Tyrol (CHRIS) study, we identified an association between a variant in the desmoplakin gene ( DSP ) and QRS, which represents the time needed for ventricular electrical activation. Downstream gene expression analyses showed that the identified variant was not associated with the expression of DSP but with that of an uncharacterized long non-coding antisense RNA, DSP-AS1 . Mendelian randomization (MR) analyses, performed leveraging publicly available data, supported a causal effect of DSP-AS1 expression on DSP expression. In vitro functional follow-up showed that silencing DSP-AS1 induces DSP transcript and desmoplakin protein upregulation, suggesting that DSP-AS1 is involved in the regulation of DSP expression and validating MR findings. Our study represents a first step in the functional characterization of DSP-AS1 , a potential target for treatment of diseases caused by low amounts of desmoplakin.
Open AccessGenomic and molecular evidence that the lncRNA DSP-AS1 modulates Desmoplakin expression
Cardiac desmosomes are specialized cell junctions responsible for cardiomyocytes mechanical coupling. Mutation in desmosomal genes cause autosomal dominant and recessive familial arrhythmogenic cardiomyopathy. Motivated by evidence that Mendelian diseases share genetic architecture with common complex traits, we assessed whether common variants in any desmosomal gene were associated with cardiac conduction traits in the general population. We analysed data of N=4342 Cooperative Health Research in South Tyrol (CHRIS) study participants. We tested associations between genotype imputed variants covering the five desmosomal genes DSP, JUP, PKP2, DSG2, and DSC2 , and P-wave, PR, QRS, and QT electrocardiographic intervals, using linear mixed models. Functional annotation and interrogation of publicly available genome-wide association study resources implicated potential connection with antisense lncRNAs, DNA methylation sites, and complex traits. Causality was tested via two-sample Mendelian randomization (MR) analysis and validated with functional in vitro follow-up in human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs). DSP variant rs2744389 was associated with QRS ( P =3.5×10 -6 ), with replication in the Microisolates in South Tyrol (MICROS) study (n=636; P =0.010). Observing that rs2744389 was associated with DSP-AS1 antisense lncRNA but not with DSP expression in multiple GTEx-v8 tissues, we conducted two-sample Mendelian randomization analyses that identified causal effects of DSP-AS1 on DSP expression ( P =6.33×10 -5 ; colocalization posterior probability=0.91) and QRS ( P =0.015). In hiPSC-CMs, DSP-AS1 expression downregulation through a specific GapmerR matching sequence led to significant DSP upregulation at both mRNA and protein levels. The evidence that DSP-AS1 has a regulatory role on DSP opens the venue for further investigations on DSP- AS1 ’s therapeutic potential for conditions caused by reduced desmoplakin production. Author Summary: Arrhythmogenic Cardiomyopathy is a severe condition mainly caused by pathogenic variants in genes encoding components of the cardiac desmosome, a specialised cell junction. Given complex traits and Mendelian diseases share common genetic background, we hypothesised that common variants in any of the five desmosomal genes ( DSP, JUP, PKP2, DSG2, and DSC2 ) could be associated with electrocardiographic measurements in general population individuals. Analyzing data from >4000 participants from the Cooperative Research In South Tyrol (CHRIS) study, we identified an association between a variant in the desmoplakin gene ( DSP ) and QRS, which represents the time needed for ventricular electrical activation. Downstream gene expression analyses showed that the identified variant was not associated with the expression of DSP but with that of an uncharacterized long non-coding antisense RNA, DSP-AS1 . Mendelian randomization (MR) analyses, performed leveraging publicly available data, supported a causal effect of DSP-AS1 expression on DSP expression. In vitro functional follow-up showed that silencing DSP-AS1 induces DSP transcript and desmoplakin protein upregulation, suggesting that DSP-AS1 is involved in the regulation of DSP expression and validating MR findings. Our study represents a first step in the functional characterization of DSP-AS1 , a potential target for treatment of diseases caused by low amounts of desmoplakin.
- 10 July 2019
- Published by Springer Nature in Stochastics and Partial Differential Equations: Analysis and Computations
- Vol. 8 (2) , 362-401
Normal approximation of the solution to the stochastic heat equation with Lévy noise
- 10 July 2019
- Published by Springer Nature in Stochastics and Partial Differential Equations: Analysis and Computations
- Vol. 8 (2) , 362-401
Normal approximation of the solution to the stochastic heat equation with Lévy noise